Postoperative surveillance for non-small cell lung cancer resected with curative intent: Developing a patient-centered approach

Annals of Thoracic Surgery

Volumn 95, Issue 3, 2013, Pages 1112-1121

  Mollberg, Nathan M ^a   Ferguson, Mark K ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; BRONCHOSCOPY; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; HEALTH CARE COST; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL HISTORY; PATIENT CARE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY;

CARCINOMA, NON-SMALL-CELL LUNG; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PATIENT-CENTERED CARE; PNEUMONECTOMY; POSTOPERATIVE PERIOD; WORLD HEALTH;

EID: 84874585927     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.09.075     Document Type: Review

References (72)

1. S.F. Altekruse, C.L. Kosary, M. Krapcho SEER Cancer Statistics Review 1975-2007 National Cancer Institute. Bethesda, MD http://seer.cancer.gov/csr/ 1975-2007 [based on November 2009 SEER data submission, posted to the SEER web site, 2010]. Accessed: April 28, 2012
2. National Lung Screening Trial Research Team D.R. Aberle, A.M. Adams, C.D. Berg et al. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
3. S. Haraguchi, K. Koizumi, T. Hirata Surgical treatment of metachronous nonsmall cell lung cancer Ann Thorac Cardiovasc Surg 16 2010 319 325
4. B.E. Lee, J.L. Port, B.M. Stiles TNM stage is the most important determinant of survival in metachronous lung cancer Ann Thorac Surg 88 2009 1100 1105
5. R.J. Battafarano, S.D. Force, B.F. Meyers Benefits of resection for metachronous lung cancer J Thorac Cardiovasc Surg 127 2004 836 842
6. Y. Tsunezuka, I. Matsumoto, M. Tamura The results of therapy for bilateral multiple primary lung cancers: 30 years experience in a single centre Eur J Surg Oncol 30 2004 781 785
7. D. Rice, H.W. Kim, A. Sabichi The risk of second primary tumors after resection of stage I non small cell lung cancer Ann Thorac Surg 76 2003 1001 1007
8. T.M. Aziz, R.A. Saad, J. Glasser, A.N. Jilaihawi, D. Prakash The management of second primary lung cancers A single centre experience in 15 years Eur J Cardiothorac Surg 21 2002 527 533
9. U. Egermann, K. Jaeggi, J.M. Habicht, A.P. Perruchoud, P. Dalquen, M. Solèr Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J 19 2002 464 468
10. J.P. Lamont, J.T. Kakuda, D. Smith, L.D. Wagman, F.W. Grannis Jr Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA Arch Surg 137 2002 935 938
11. F. Rea, A. Zuin, D. Callegaro, L. Bortolotti, G. Guanella, F. Sartori Surgical results for multiple primary lung cancers Eur J Cardiothorac Surg 20 2001 489 495
12. C. Doddoli, P. Thomas, O. Ghez, R. Giudicelli, P. Fuentes Surgical management of metachronous bronchial carcinoma Eur J Cardiothorac Surg 19 2001 899 903
13. J. Van Meerbeeck, J. Weyler, A. Thibaut Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis Lung Cancer 15 1996 281 295
14. J.M. Pepek, J.P. Chino, L.B. Marks How well does the new lung cancer staging system predict for local/regional recurrence after surgery? A comparison of the TNM 6 and 7 systems J Thorac Oncol 6 2011 757 761
15. C. Endo, A. Sakurada, H. Notsuda Results of long-term follow-up of patients with completely resected non-small cell lung cancer Ann Thorac Surg 93 2012 1061 1068
16. J.J. Hung, W.H. Hsu, C.C. Hsieh Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence Thorax 64 2009 192 196
17. K. Okubo, T. Bando, R. Miyahara Resection of pulmonary metastasis of non-small cell lung cancer J Thorac Oncol 4 2009 203 207
18. T. Nakagawa, N. Okumura, K. Ohata, H. Igai, T. Matsuoka, K. Kameyama Postrecurrence survival in patients with stage I non-small cell lung cancer Eur J Cardiothorac Surg 34 2008 499 504
19. H. Sugimura, F.C. Nichols, P. Yang Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection Ann Thorac Surg 83 2007 409 417
20. H.S. Kim HS, Y.S. Choi, K. Kim, Y.M. Shim, J. Kim Surgical resection of recurrent lung cancer in patients following curative resection I H J Korean Med Sci 21 2006 224 228
21. T. Hishida, K. Nagai, J. Yoshida Is surgical resection indicated for a solitary non-small cell lung cancer recurrence? J Thorac Cardiovasc Surg 131 2006 838 842
22. L. Voltolini, P. Paladini, L. Luzzi, C. Ghiribelli, M. Di Bisceglie, G. Gotti Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma Eur J Cardiothorac Surg 18 2000 529 534
23. V. Westeel, D. Choma, F. Clement Relevance of an intensive postoperative follow-up after surgery for non-small lung cancer Ann Thorac Surg 70 2000 1185 1190
24. R.N. Younes, J.L. Gross, D. Deheinzelin Follow-up in lung cancer: how often and for what purpose? Chest 115 1999 1494 1499
25. G.L. Walsh, M. O'Connor, K.M. Willis Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 60 1995 1563 1570 discussion 1570-2
26. K.S. Virgo, L.W. McKirgan, M.C. Caputo Post-treatment management options for patients with lung cancer Ann Surg 222 1995 700 710
27. R. Benamore, F.A. Shepherd, N. Leighl Does intensive follow-up alter outcome in patients with advanced lung cancer? J Thorac Oncol 2 2007 273 281
28. O.U. Ataman, A. Barrett, T. Filleron, A. Kramar ESTRO-REACT Group Optimization of follow-up timing from study of patterns of first failure after primary treatment An example from patients with NSCLC: a study of the REACT working group of ESTRO Radiother Oncol 78 2006 95 100
29. N. Martini, M.R. Melamed Multiple primary lung cancers J Thorac Cardiovasc Surg 70 1975 606 611
30. T. Antakli, R.F. Schaefer, J.E. Rutherford, R.C. Read Second primary lung cancer Ann Thorac Surg 59 1995 863 867
31. N. Martini, M.S. Bains, M.E. Burt Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
32. T. Yano, H. Yokoyama, T. Inoue The first site of recurrence after complete resection in non-small-cell carcinoma of the lung Comparison between pN0 disease and pN2 disease J Thorac Cardiovasc Surg 108 1994 680 683
33. C.R. Kelsey, L.B. Marks, D. Hollis Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients Cancer 115 2009 5218 5227
34. J.M. Varlotto, A. Recht, J.C. Flickinger, L.N. Medford-Davis, A.M. Dyer, M.M. DeCamp Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I non small cell lung cancer Cancer 116 2010 2390 2400
35. K. al-Kattan, E. Sepsas, S.W. Fountain, E.R. Townsend Disease recurrence after resection for stage I lung cancer Eur J Cardiothorac Surg 12 1997 380 384
36. R. Demicheli, M. Fornili, F. Ambrogi Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases J Thorac Oncol 7 2012 723 730
37. R.J. Ginsberg, L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer Ann Thorac Surg 60 1995 615 623
38. T. Koike, Y. Yamato, K. Yoshiya Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer J Thorac Cardiovasc Surg 125 2003 924 928
39. M. Okada, K. Yoshikawa, T. Hatta Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 71 2001 956 961
40. M.K. Ferguson, A.G. Lehman Sleeve lobectomy or pneumonectomy: optimal management strategy using decision analysis techniques Ann Thorac Surg 76 2003 1782 1788
41. J. Deslauriers, J. Gregoire, L.F. Jacques Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences Ann Thorac Surg 77 2004 1152 1156
42. E. Vallières, P. Van Houtte, W.D. Travis, R. Rami-Porta, P. Goldstraw International Association for the Study of Lung Cancer (IASLC) International Staging Committee Carcinoma in situ at the bronchial resection margin: a review J Thorac Oncol 6 2011 1617 1623
43. J. Wind, E.J. Smit, S. Senan, J.P. Eerenberg Residual disease at the bronchial stump after curative resection for lung cancer Eur J Cardiothorac Surg 32 2007 29 34
44. T.E. Sawyer, J.A. Bonner, P.M. Gould Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials Int J Radiat Oncol Biol Phys 45 1999 315 321
45. J.J. Hung, W.J. Jeng, W.H. Hsu, T.Y. Chou, B.S. Huang, Y.C. Wu Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer J Thorac Oncol 7 2012 1115 1123
46. G.E. Darling, M.S. Allen, P.A. Decker Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial J Thorac Cardiovasc Surg 141 2011 662 670
47. J.M. Varlotto, A. Recht, J.C. Flickinger, L.N. Medford-Davis, A.M. Dyer, M.M. Decamp Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer Cancer 115 2009 1059 1069
48. H.K. Koo, S.M. Jin, C.H. Lee Factors associated with recurrence in patients with curatively resected stage I-II lung cancer Lung Cancer 73 2011 222 229
49. K.A. Higgins, J.P. Chino, N. Ready Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy J Thorac Oncol 7 2012 1141 1147
50. K.M. Jang, K.S. Lee, Y.M. Shim The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumor staging J Thorac Imaging 8 2003 225 230
51. E.H. Baldini, M.M. DeCamp Jr, M.S. Katz Patterns of recurrence and outcome for patients with clinical stage II nonsmall- cell lung cancer Am J Clin Oncol 22 1999 8 14
52. Y. Ichinose, H. Kato, T. Koike Japan Clinical Oncology Group Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials Lung Cancer 34 2001 29 36
53. J. Varlotto, L.N. Medford-Davis, A. Recht Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer Lung Cancer 75 2012 381 390
54. P.A. Thomas, L. Rubinstein Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer The Lung Cancer Study Group J Thorac Cardiovasc Surg 106 1993 1053 1058
55. M.A. Razzuk, M. Pockey, H.C. Urschel, D.L. Paulson Dual primary bronchogenic carcinoma Ann Thorac Surg 17 1974 425 433
56. P.C. Pairolero, D.E. Williams, E.J. Bergstralh, J.M. Piehler, P.E. Bernatz, W.S. Payne Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease Ann Thorac Surg 38 1984 331 338
57. R.M. Flores, U.N. Ihekweazu, N. Rizk Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer J Thorac Cardiovasc Surg 141 2011 59 64
58. T. Shiraishi, T. Shirakusa, M. Hiratsuka, S. Yamamoto, A. Iwasaki Video-assisted thoracoscopic surgery lobectomy for c-T1N0M0 primary lung cancer: its impact on locoregional control Ann Thorac Surg 82 2006 1021 1026
59. F. Levi, L. Randimbison, V.C. Te, C. La Vecchia Second primary cancers in patients with lung carcinoma Cancer 86 1999 186 190
60. H. Sugimura, S. Watanabe, S. Tsugane, S. Morinaga, T. Yoneyama Case control study on histologically determined multiple primary lung cancer J Natl Cancer Inst 79 1987 435 441
61. M.S. Kent, P. Korn, J.L. Port, P.C. Lee, N.K. Altorki, R.J. Korst Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model Ann Thorac Surg 80 2005 1215 1222
62. R.J. Korst, A.L. Kansler, J.L. Port, P.C. Lee, N.K. Altorki Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer Ann Thorac Surg 82 2006 1009 1015
63. C.H. Chiu, M.S. Chern, M.H. Wu Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: preliminary report J Thorac Cardiovasc Surg 125 2003 1300 1305
64. D. Hellwig, A. Groschel, T.P. Graeter Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer Eur J Nucl Med Mol Imaging 33 2006 13 21
65. R.J. Hicks, V. Kalff, M.P. MacManus The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification J Nucl Med 42 2001 1605 1613
66. T.L. Weigel, P.J. Kosco, S. Dacic, V.W. Rusch, R.J. Ginsberg, J.D. Luketich Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients Ann Thorac Surg 71 2001 967 970
67. National Comprehensive Cancer Network (NCCN) Guidelines in Oncology: Non-Small Cell Carcinoma http://www.nccn.org/professionals/physician-gls/PDF/ nscl.pdf Accessed: March 4, 2012
68. J. Rubins, M. Unger, G.L. Colice American College of Chest Physicians Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition) Chest 132 3 Suppl 2007 355S 367S
69. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 2004 330 353
70. L. Crinò, W. Weder, J. van Meerbeeck, E. Felip ESMO Guidelines Working Group Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl 5 2010 v103 v115
71. W.T. Sause, R.W. Byhardt, W.J. Curran Jr Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria Radiology 215 Suppl 2000 1363 1372
72. http://aats.org/multimedia/files/Guidelines/Lung-Cancer-Screening-Using- low-dose-computed-tomography-scans.pdf Accessed June 22, 2012